eCite Digital Repository
Whole-exome sequencing in multiplex preeclampsia families identifies novel candidate susceptibility genes
Citation
Melton, PE and Johnson, MP and Gokhale-Agashe, D and Rea, AJ and Ariff, A and Cadby, G and Peralta, JM and McNab, TJ and Allcock, RJn and Abraham, LJ and Blangero, J and Brennecke, SP and Moses, EK, Whole-exome sequencing in multiplex preeclampsia families identifies novel candidate susceptibility genes, Journal of Hypertension, 37, (5) pp. 997-1011. ISSN 0263-6352 (2019) [Refereed Article]
Copyright Statement
Copyright 2019 Wolters Kluwer Health, Inc. All rights reserved.
DOI: doi:10.1097/HJH.0000000000002023
Abstract
Objective: Preeclampsia is a common and serious heritable disorder of human pregnancy. Although there have been notable successes in identification of maternal susceptibility genes a large proportion of the heritability of preeclampsia remains unaccounted for. It is has been postulated that rare variation may account for some of this missing heritability. In this study, we performed whole-exome sequencing (WES) in multiplex families to identify rare exonic risk variants.
Methods: We conducted WES in 244 individuals from 34 Australian/New Zealand multiplex preeclampsia families. Variants were tested for association with preeclampsia using a threshold model and logistic regression.
Results: We found significant association for two moderately rare missense variants, rs145743393 (Padj = 0.0032, minor allele frequency = 0.016) in the chromosome 1 open reading frame 35 (C1orf35) gene, and rs34270076 (Padj = 0.0128, minor allele frequency = 0.024) in the pyroglutamylated RFamide peptide receptor (QRFPR) gene. To replicate these associations we performed imputation in our Australian genome wide association scan for preeclampsia and found no significant exonic variants in either C1orf35 or QRFPR. However, 11 variants demonstrating nominal significance (P < 0.05) in the genomic region between QRFPR and annexin A5 (ANXA5) were identified. We further leveraged publicly available genome-wide available summary data from the UK Biobank to investigate association of these two variants with the underlying clinical phenotypes of preeclampsia and detected nominal association of the QRFPR variant (rs34270076, P = 0.03) with protein levels in females.
Conclusion: The study represents the first to use WES in multiplex families for preeclampsia and identifies two novel genes (QRFPR and C1orf35) not previously associated with preeclampsia and find nominal association of rs34270076 with protein levels, a key clinical feature of preeclampsia. We find further support for ANXA5 previously associated with pregnancy complications, including preeclampsia.
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | preeclampsia, whole-exome sequencing, QRFPR, C1orf35 |
Research Division: | Biological Sciences |
Research Group: | Genetics |
Research Field: | Gene mapping |
Objective Division: | Health |
Objective Group: | Clinical health |
Objective Field: | Clinical health not elsewhere classified |
UTAS Author: | Melton, PE (Dr Phillip Melton) |
ID Code: | 141382 |
Year Published: | 2019 |
Web of Science® Times Cited: | 8 |
Deposited By: | Menzies Institute for Medical Research |
Deposited On: | 2020-10-16 |
Last Modified: | 2021-06-03 |
Downloads: | 0 |
Repository Staff Only: item control page